A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients

This study has been completed.
Sponsor:
Collaborator:
University of Manchester
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
ClinicalTrials.gov Identifier:
NCT01445652
First received: September 30, 2011
Last updated: June 29, 2012
Last verified: June 2012

September 30, 2011
June 29, 2012
September 2011
June 2012   (final data collection date for primary outcome measure)
  • Subjective Happiness with Correction Type [ Time Frame: After 6 months of wear ] [ Designated as safety issue: No ]
    As reported via SMS message. Subjective happiness with correction type will be interpreted and rated by the participant on a 5-point scale, with 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good.
  • Subjective Vision with Correction Type [ Time Frame: After 6 months of wear ] [ Designated as safety issue: No ]
    As reported via SMS message. Subjective vision with correction type will be interpreted and rated by the participant on a 5-point scale, with 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good.
Same as current
Complete list of historical versions of study NCT01445652 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients
A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients

The purpose of this study is to evaluate the relative benefits of daily disposable contact lenses versus spectacles in young adults.

This 6-month study seeks to compare the relative benefits of contact lenses and spectacles in subjects aged 13-19 years.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Myopia
  • Device: nelfilcon A contact lens
    Commercially marketed, single vision, soft contact lens for daily disposable wear
    Other Name: DAILIES AQUACOMFORT PLUS
  • Other: Spectacles
    Spectacles per current prescription
  • Experimental: nelfilcon A
    Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months
    Intervention: Device: nelfilcon A contact lens
  • Active Comparator: Spectacles
    Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months
    Intervention: Other: Spectacles
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
110
June 2012
June 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Between 13 and 19 years, inclusive.
  • Understand rights as a research subject and is willing and able to sign a Statement of Informed Consent, or if under 18, a parent or guardian understands rights and is willing and able to sign a Statement of Informed Consent.
  • Willing and able to follow the protocol.
  • Currently wearing spectacles full-time (at least five days per week, eight hours per day).
  • Has never worn contact lenses (more than one day) before.
  • Agrees to not participate in other clinical research for the duration of this study.
  • Can attain at least 6/9 in each eye with the study optical correction.
  • Can be fitted with study lenses in the available power range (contact lens group) or can select a satisfactory spectacle lens frame and lenses (spectacle group).
  • Willing and able to wear the study lenses or spectacles for a minimum of five days per week, eight hours per day.
  • Owns or has regular access to a mobile phone and is familiar with SMS text messaging.
  • Has an up-to-date and functional pair of spectacles at time of enrollment.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Has an ocular or systemic disorder that would normally contraindicate contact lens wear.
  • Is using any topical medication such as eye drops or ointment.
  • Has had corneal refractive surgery.
  • Has had cataract surgery.
  • Has diabetes.
  • Has taken part in other clinical research within two weeks of starting the study.
  • Other protocol-defined exclusion criteria may apply.
Both
13 Years to 19 Years
No
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
NCT01445652
P-370-C-091 / CB11-500
No
Alcon Research ( CIBA VISION )
CIBA VISION
University of Manchester
Principal Investigator: Philip Morgan, PhD MCOptom FAAO FBCLA University of Manchester
Alcon Research
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP